Tuesday 16 April 2019 (-1st Week, Trinity Term)

• 12:00 - The Triple Win: how the UK can achieve personalised medicine, a growing life science sector, and an affordable NHS
  Lord James O'Shaughnessy
  Department of Oncology

Monday 3 June 2019 (6th Week, Trinity Term)

• 11:00 - Aberrant ubiquitin networks in B cell neoplasms
  Prof. Dr. Florian Bassermann (Department of Medicine III (Hematology/Oncology) Technical University of Munich)

Wednesday 12 June 2019 (7th Week, Trinity Term)

• 12:00 - Consequences of compromised TGFbeta signaling in cancer on response to therapy
  Professor Mary Helen Barcellos-Hoff (Research Department of Radiation Oncology, University of California, San Francisco School of Medicine

Thursday 13 June 2019 (7th Week, Trinity Term)

• 11:00 - Ubiquitin, signaling in normal and cancer cell cycles
  Michael J. Emanuele (UNC School Medicine, University of Virginia)
  Department of Oncology

Friday 12 July 2019 (11th Week, Trinity Term)

• 11:00 - Radiotherapy as Immunotherapy
  Professor Alan Melcher (Translational Immunology, The Institute of Cancer Research)
  Department of Oncology

Thursday 25 July 2019 (13th Week, Trinity Term)

• 12:00 - Degrading activities: Regulation of cellular biology by the ubiquitous pathway
  Professor David P. Toczyski (University of California San Francisco)
  Department of Oncology

Monday 2 September 2019 (19th Week, Trinity Term)

• 11:00 - Reducing tumor hypoxia with mitochondrial inhibitors, translation to clinical studies
  Professor Nicolas Denko (The Ohio State University Wexner Medical Center)
  Department of Oncology

Friday 20 September 2019 (21st Week, Trinity Term)

• 11:00 - Developing Affinity-Based Therapies for Targeting Metastatic Cancers
  Dr. Yu Rebecca Miao (Dept. Radiation Oncology, Stanford University )
  Department of Oncology

Tuesday 1 October 2019 (-1st Week, Michaelmas Term)

• 10:00 - Cell Programming
  Professor Duanqing Pei (Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences)

Monday 7 October 2019 (0th Week, Michaelmas Term)

• 14:00 - Clinical relevance of hyper-recombination in cancer
  Dr. Anand Jeyasekharan (Consultant, Department of Haematology-Oncology, National University Hospital Singapore, and PI at the Cancer Science Institute, National University of Singapore)
  Department of Oncology